<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               PRECAUTIONS<BR>               <BR>                  PRECAUTIONS<BR>                  General<BR>              RIFATER should be used with caution in patients with a history of<BR>              diabetes mellitus, as diabetes management may be more difficult.<BR>            <BR>                  <BR>                  Rifampin<BR>              For treatment of tuberculosis, rifampin is usually administered<BR>              on a daily basis. Doses of rifampin ( 600 mg) given once or twice weekly have<BR>              resulted in a higher incidence of adverse reactions, including the "flu<BR>              syndrome" (fever, chills and malaise); hematopoietic reactions (leukopenia,<BR>              thrombocytopenia, or acute hemolytic anemia); cutaneous, gastrointestinal, and<BR>              hepatic reactions; shortness of breath; shock and renal failure.<BR>            <BR>                  <BR>              The patient should be advised that the reliability of oral contraceptives may<BR>              be affected; consideration should be given to using alternative contraceptive<BR>              measures.<BR>            <BR>                  Isoniazid<BR>              All drugs should be stopped and an evaluation of the patient<BR>              should be made at the first sign of a hypersensitivity reaction.<BR>            <BR>                  <BR>              Use of RIFATER, because it contains isoniazid, should be carefully monitored<BR>              in the following:<BR>            <BR>                  <BR>                     <BR>                Patients who are receiving phenytoin (diphenylhydantoin) concurrently.<BR>                Isoniazid may decrease the excretion of phenytoin or may enhance its effects. To<BR>                avoid phenytoin intoxication, appropriate adjustment of the anticonvulsant dose<BR>                should be made.<BR>              <BR>                     <BR>                Daily users of alcohol. Daily ingestion of alcohol may be associated with a<BR>                higher incidence of isoniazid hepatitis.<BR>              <BR>                            3. Patients with current chronic liver disease or severe renal dysfunction.<BR><BR>                  <BR><BR>                  Pyrazinamide<BR>              Pyrazinamide inhibits renal excretion of urates, frequently<BR>              resulting in hyperuricemia which is usually asymptomatic. If hyperuricemia is<BR>              accompanied by acute gouty arthritis, RIFATER, because it contains pyrazinamide,<BR>              should be discontinued.<BR>            <BR>                  <BR><BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>